Cargando…

Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up

Chronic anthracycline cardiotoxicity is a serious clinical issue with well characterized functional and histopathological hallmarks. However, molecular determinants of the toxic damage and associated myocardial remodeling remain to be established. Furthermore, details on the different propensity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenčová-Popelová, Olga, Jirkovský, Eduard, Mazurová, Yvona, Lenčo, Juraj, Adamcová, Michaela, Šimůnek, Tomáš, Geršl, Vladimír, Štěrba, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013127/
https://www.ncbi.nlm.nih.gov/pubmed/24804796
http://dx.doi.org/10.1371/journal.pone.0096055
_version_ 1782315016072986624
author Lenčová-Popelová, Olga
Jirkovský, Eduard
Mazurová, Yvona
Lenčo, Juraj
Adamcová, Michaela
Šimůnek, Tomáš
Geršl, Vladimír
Štěrba, Martin
author_facet Lenčová-Popelová, Olga
Jirkovský, Eduard
Mazurová, Yvona
Lenčo, Juraj
Adamcová, Michaela
Šimůnek, Tomáš
Geršl, Vladimír
Štěrba, Martin
author_sort Lenčová-Popelová, Olga
collection PubMed
description Chronic anthracycline cardiotoxicity is a serious clinical issue with well characterized functional and histopathological hallmarks. However, molecular determinants of the toxic damage and associated myocardial remodeling remain to be established. Furthermore, details on the different propensity of the left and right ventricle (LV and RV, respectively) to the cardiotoxicity development are unknown. Hence, the aim of the investigation was to study molecular changes associated with remodeling of the LV and RV in chronic anthracycline cardiotoxicity and post-treatment follow up. The cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg/week for 10 weeks) and animals were sacrificed either at the end of the treatment or after an additional 10 weeks. Daunorubicin induced severe and irreversible cardiotoxicity associated with LV dysfunction and typical morphological alterations, whereas the myocardium of the RV showed only mild changes. Both ventricles also showed different expression of ANP after daunorubicin treatment. Daunorubicin impaired the expression of several sarcomeric proteins in the LV, which was not the case of the RV. In particular, a significant drop was found in titin and thick filament proteins at both mRNA and protein level and this might be connected with persistent LV down-regulation of GATA-4. In addition, the LV was more affected by treatment-induced perturbations in calcium handling proteins. LV cardiomyocytes showed marked up-regulation of desmin after the treatment and vimentin was mainly induced in LV fibroblasts, whereas only weaker changes were observed in the RV. Remodeling of extracellular matrix was almost exclusively found in the LV with particular induction of collagen I and IV. Hence, the present study describes profound molecular remodeling of myocytes, non-myocyte cells and extracellular matrix in response to chronic anthracycline treatment with marked asymmetry between LV and RV.
format Online
Article
Text
id pubmed-4013127
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40131272014-05-09 Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up Lenčová-Popelová, Olga Jirkovský, Eduard Mazurová, Yvona Lenčo, Juraj Adamcová, Michaela Šimůnek, Tomáš Geršl, Vladimír Štěrba, Martin PLoS One Research Article Chronic anthracycline cardiotoxicity is a serious clinical issue with well characterized functional and histopathological hallmarks. However, molecular determinants of the toxic damage and associated myocardial remodeling remain to be established. Furthermore, details on the different propensity of the left and right ventricle (LV and RV, respectively) to the cardiotoxicity development are unknown. Hence, the aim of the investigation was to study molecular changes associated with remodeling of the LV and RV in chronic anthracycline cardiotoxicity and post-treatment follow up. The cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg/week for 10 weeks) and animals were sacrificed either at the end of the treatment or after an additional 10 weeks. Daunorubicin induced severe and irreversible cardiotoxicity associated with LV dysfunction and typical morphological alterations, whereas the myocardium of the RV showed only mild changes. Both ventricles also showed different expression of ANP after daunorubicin treatment. Daunorubicin impaired the expression of several sarcomeric proteins in the LV, which was not the case of the RV. In particular, a significant drop was found in titin and thick filament proteins at both mRNA and protein level and this might be connected with persistent LV down-regulation of GATA-4. In addition, the LV was more affected by treatment-induced perturbations in calcium handling proteins. LV cardiomyocytes showed marked up-regulation of desmin after the treatment and vimentin was mainly induced in LV fibroblasts, whereas only weaker changes were observed in the RV. Remodeling of extracellular matrix was almost exclusively found in the LV with particular induction of collagen I and IV. Hence, the present study describes profound molecular remodeling of myocytes, non-myocyte cells and extracellular matrix in response to chronic anthracycline treatment with marked asymmetry between LV and RV. Public Library of Science 2014-05-07 /pmc/articles/PMC4013127/ /pubmed/24804796 http://dx.doi.org/10.1371/journal.pone.0096055 Text en © 2014 Lenčová-Popelová et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lenčová-Popelová, Olga
Jirkovský, Eduard
Mazurová, Yvona
Lenčo, Juraj
Adamcová, Michaela
Šimůnek, Tomáš
Geršl, Vladimír
Štěrba, Martin
Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up
title Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up
title_full Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up
title_fullStr Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up
title_full_unstemmed Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up
title_short Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up
title_sort molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013127/
https://www.ncbi.nlm.nih.gov/pubmed/24804796
http://dx.doi.org/10.1371/journal.pone.0096055
work_keys_str_mv AT lencovapopelovaolga molecularremodelingofleftandrightventricularmyocardiuminchronicanthracyclinecardiotoxicityandposttreatmentfollowup
AT jirkovskyeduard molecularremodelingofleftandrightventricularmyocardiuminchronicanthracyclinecardiotoxicityandposttreatmentfollowup
AT mazurovayvona molecularremodelingofleftandrightventricularmyocardiuminchronicanthracyclinecardiotoxicityandposttreatmentfollowup
AT lencojuraj molecularremodelingofleftandrightventricularmyocardiuminchronicanthracyclinecardiotoxicityandposttreatmentfollowup
AT adamcovamichaela molecularremodelingofleftandrightventricularmyocardiuminchronicanthracyclinecardiotoxicityandposttreatmentfollowup
AT simunektomas molecularremodelingofleftandrightventricularmyocardiuminchronicanthracyclinecardiotoxicityandposttreatmentfollowup
AT gerslvladimir molecularremodelingofleftandrightventricularmyocardiuminchronicanthracyclinecardiotoxicityandposttreatmentfollowup
AT sterbamartin molecularremodelingofleftandrightventricularmyocardiuminchronicanthracyclinecardiotoxicityandposttreatmentfollowup